http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35935393

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 1648
issn 1460-2091
0305-7453
issueIdentifier 7
pageRange 1644-1648
publicationName The Journal of antimicrobial chemotherapy
startingPage 1644
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_86f2c7a4dfe6043cd7327cf263134a05
bibliographicCitation Huygens S, Gharbharan A, Serroukh Y, Snoek B, Franken B, Oude Munnink BB, Van Hagen PM, Bogers S, Geurtsvankessel CH, Rijnders BJA. High-titer convalescent plasma plus nirmatrelvir/ritonavir treatment for non-resolving COVID-19 in six immunocompromised patients. J Antimicrob Chemother. 2023 Jul 05;78(7):1644–8. PMID: 37248664; PMCID: PMC10320105.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dfb63a0babd91c539f721dd62a61a935
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3343-9610
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ed7555f7b9735f0c61c58148c005932
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c050af65bd42325298d05722fa3f8f4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_388288fe4aa74ace42ccfa0e6daf2fc7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_034d71c9fa0daf458956501551473a40
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c9561dd479e4aec8e2d1246426799d28
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ec01dc8f0a5e18c6de0348a0c4ca73e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_142218524ca0224a3be6c6b5ef99e56b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa46e6e1dd0d0bd24f316d5824e2c5e6
date 2023-05-30^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1093/jac/dkad144
https://pubmed.ncbi.nlm.nih.gov/37248664
https://pubmed.ncbi.nlm.nih.gov/PMC10320105
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4495
https://portal.issn.org/resource/ISSN/0305-7453
https://portal.issn.org/resource/ISSN/1460-2091
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title High-titer convalescent plasma plus nirmatrelvir/ritonavir treatment for non-resolving COVID-19 in six immunocompromised patients
discusses http://id.nlm.nih.gov/mesh/M0028918
http://id.nlm.nih.gov/mesh/M0001518
http://id.nlm.nih.gov/mesh/M000750527
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000086382Q000628
hasSubjectTerm http://id.nlm.nih.gov/mesh/D016867
http://id.nlm.nih.gov/mesh/D019438Q000627
http://id.nlm.nih.gov/mesh/D000093522
http://id.nlm.nih.gov/mesh/D000093485
http://id.nlm.nih.gov/mesh/D000086402
http://id.nlm.nih.gov/mesh/D000998Q000627
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID392622
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8153
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_89d708279e197fec68596fc46bc48c90
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0943bfb20a0e8ebccd479b74c7b652df

Showing number of triples: 1 to 47 of 47.